List of all submitters

Displaying the submitter´s press releases: Helsinn Healthcare SA

Press releases found: 1

Helsinn Group and Angelini Ink an Agreement for License Rights to Phase-III Ghrelin Receptor Agonist Anamorelin in Central & Eastern Europe

15.01.2014 14:33

Submitter: Helsinn Healthcare SA

Press releases found: 1